@inproceedings{inproceedings, title = {{Sustained long-term dupilumab efficacy in adult patients with moderate-to-severe atopic dermatitis transitioning from weekly dosing to every other week: Results from an open-label extension trial}},
url = {{}},
year = {{2022}},
month = {{1}},
author = {{Cork MJ and Beck LA and Deleuran M and Hong HC-H and Adam DN and Hussain I and Zhang H and Shabbir A and Rodriguez Marco A and Levit NA}},
volume = {{52}},
journal = {{CLINICAL AND EXPERIMENTAL ALLERGY}},
issue = {{8}},
pages = {{1014-1014}},
note = {{Accessed on 2025/07/16}}}